US Pharma MarketingThe post AI’s use on existing radiology reports sees 360% rise in steatotic liver patient identification appeared first on Medical Device Network.
AI’s use on existing radiology reports sees 360% rise in steatotic liver patient identification
Using its AIRE platform, Briya identified an additional 4,036 patients with a steatotic liver, expanding the relevant study population from 1,122 to 5,158 patients. Using its AIRE platform, Briya identified an additional 4,036 patients with a steatotic liver, expanding the relevant study population from 1,122 to 5,158 patients. GlobalData analysis projects that AI in healthcare will reach a valuation of around $57.4bn in 2029. Credit: S. Singha/Shutterstock.com Using an artificial intelligence (AI)-based platform in a large real-world analysis of ultrasound radiology reports led to a more than three-fold increase in identified metabolic dysfunction-associated steatotic liver disease (MASLD) patients – signalling…
Using its AIRE platform, Briya identified an additional 4,036 patients with a steatotic liver, expanding the relevant study population from 1,122 to 5,158 patients.
Source: Medical Device Network